PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

This adverse event was reported 117 times

PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPCORITAMAB-BYSP 4 0.0030
1 AXICABTAGENE CILOLEUCEL 28 0.0028
2 SILTUXIMAB 1 0.0015
3 ETOPOSIDE PHOSPHATE 2 0.0012
4 CHLOROTHIAZIDE SODIUM 1 0.0011
5 CHLOROTHIAZIDE 1 0.0008
6 POLATUZUMAB VEDOTIN 8 0.0008
7 VINORELBINE 5 0.0007
8 ARGATROBAN 1 0.0007
9 IBRITUMOMAB TIUXETAN 1 0.0007
See all drugs enriched for association with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA